Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

BST-2 expression in human hepatocytes is inducible by all three types of interferons and restricts production of hepatitis C virus.

Amet T, Byrd D, Hu N, Sun Q, Li F, Zhao Y, Hu S, Grantham A, Yu Q.

Curr Mol Med. 2014 Mar;14(3):349-60.

PMID:
24236455
2.

Modulation of hepatitis C virus release by the interferon-induced protein BST-2/tetherin.

Dafa-Berger A, Kuzmina A, Fassler M, Yitzhak-Asraf H, Shemer-Avni Y, Taube R.

Virology. 2012 Jul 5;428(2):98-111. doi: 10.1016/j.virol.2012.03.011. Epub 2012 Apr 20.

3.

The Interferon-Inducible Protein Tetherin Inhibits Hepatitis B Virus Virion Secretion.

Yan R, Zhao X, Cai D, Liu Y, Block TM, Guo JT, Guo H.

J Virol. 2015 Sep;89(18):9200-12. doi: 10.1128/JVI.00933-15. Epub 2015 Jun 24.

4.

[Effects of different types of interferon on the expression of HCV replication-related microRNA].

Chen H, Ye L, Su J, Jiang D, Li Y, Zeng J, Ruan Z.

Zhonghua Yi Xue Za Zhi. 2014 Mar 18;94(10):776-9. Chinese.

PMID:
24844965
5.

BST2/Tetherin inhibits hepatitis C virus production in human hepatoma cells.

Pan XB, Qu XW, Jiang D, Zhao XL, Han JC, Wei L.

Antiviral Res. 2013 Apr;98(1):54-60. doi: 10.1016/j.antiviral.2013.01.009. Epub 2013 Feb 16.

PMID:
23422647
6.

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R.

Hepatology. 2012 Dec;56(6):2082-93. doi: 10.1002/hep.25908. Epub 2012 Oct 14.

PMID:
22711689
7.

TLR-4 engagement of dendritic cells confers a BST-2/tetherin-mediated restriction of HIV-1 infection to CD4+ T cells across the virological synapse.

Blanchet FP, Stalder R, Czubala M, Lehmann M, Rio L, Mangeat B, Piguet V.

Retrovirology. 2013 Jan 11;10:6. doi: 10.1186/1742-4690-10-6.

8.

Ribavirin enhances the action of interferon-α against hepatitis C virus by promoting the p53 activity through the ERK1/2 pathway.

Liu WL, Yang HC, Su WC, Wang CC, Chen HL, Wang HY, Huang WH, Chen DS, Lai MY.

PLoS One. 2012;7(9):e43824. doi: 10.1371/journal.pone.0043824. Epub 2012 Sep 4.

9.

DDX60L Is an Interferon-Stimulated Gene Product Restricting Hepatitis C Virus Replication in Cell Culture.

Grünvogel O, Esser-Nobis K, Reustle A, Schult P, Müller B, Metz P, Trippler M, Windisch MP, Frese M, Binder M, Fackler O, Bartenschlager R, Ruggieri A, Lohmann V.

J Virol. 2015 Oct;89(20):10548-68. doi: 10.1128/JVI.01297-15. Epub 2015 Aug 12.

10.

Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo.

Pillai SK, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene WC, Kovari H, Rauch A, Fellay J, Battegay M, Hirschel B, Witteck A, Bernasconi E, Ledergerber B, Günthard HF, Wong JK; Swiss HIV Cohort Study.

Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3035-40. doi: 10.1073/pnas.1111573109. Epub 2012 Feb 6.

11.

Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Ye L, Wang X, Li J, Liu J, Ramirez SH, Wu J, Ho W.

Innate Immun. 2012 Jun;18(3):398-405. doi: 10.1177/1753425911412984. Epub 2011 Sep 22.

12.

Identification of BST-2/tetherin-induced hepatitis B virus restriction and hepatocyte-specific BST-2 inactivation.

Lv M, Zhang B, Shi Y, Han Z, Zhang Y, Zhou Y, Zhang W, Niu J, Yu XF.

Sci Rep. 2015 Jun 29;5:11736. doi: 10.1038/srep11736.

13.

Interferon alpha decreases expression of human scavenger receptor class BI, a possible HCV receptor in hepatocytes.

Murao K, Imachi H, Yu X, Cao WM, Nishiuchi T, Chen K, Li J, Ahmed RA, Wong NC, Ishida T.

Gut. 2008 May;57(5):664-71. Epub 2007 Nov 12.

PMID:
17998316
14.

The interferon-inducible host factor bone marrow stromal antigen 2/tetherin restricts virion release, but is it actually a viral restriction factor?

Andrew A, Strebel K.

J Interferon Cytokine Res. 2011 Jan;31(1):137-44. doi: 10.1089/jir.2010.0108. Epub 2010 Dec 19. Review.

15.

Interferon-inducible cholesterol-25-hydroxylase restricts hepatitis C virus replication through blockage of membranous web formation.

Anggakusuma, Romero-Brey I, Berger C, Colpitts CC, Boldanova T, Engelmann M, Todt D, Perin PM, Behrendt P, Vondran FW, Xu S, Goffinet C, Schang LM, Heim MH, Bartenschlager R, Pietschmann T, Steinmann E.

Hepatology. 2015 Sep;62(3):702-14. doi: 10.1002/hep.27913. Epub 2015 Jul 28.

PMID:
25999047
16.

Influenza virus partially counteracts restriction imposed by tetherin/BST-2.

Mangeat B, Cavagliotti L, Lehmann M, Gers-Huber G, Kaur I, Thomas Y, Kaiser L, Piguet V.

J Biol Chem. 2012 Jun 22;287(26):22015-29. doi: 10.1074/jbc.M111.319996. Epub 2012 Apr 6.

17.

Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.

Bauhofer O, Ruggieri A, Schmid B, Schirmacher P, Bartenschlager R.

Gastroenterology. 2012 Aug;143(2):429-38.e8. doi: 10.1053/j.gastro.2012.04.018. Epub 2012 Apr 19.

PMID:
22522091
18.

Bile acids promote the expression of hepatitis C virus in replicon-harboring cells.

Chang KO, George DW.

J Virol. 2007 Sep;81(18):9633-40. Epub 2007 Jul 3.

19.

Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling.

Bego MG, Mercier J, Cohen EA.

J Virol. 2012 Apr;86(7):3513-27. doi: 10.1128/JVI.06971-11. Epub 2012 Feb 1.

20.

Natural killer cells inhibit hepatitis C virus expression.

Li Y, Zhang T, Ho C, Orange JS, Douglas SD, Ho WZ.

J Leukoc Biol. 2004 Dec;76(6):1171-9. Epub 2004 Aug 31.

PMID:
15339939

Supplemental Content

Support Center